vs

Side-by-side financial comparison of MEDIFAST INC (MED) and TACTILE SYSTEMS TECHNOLOGY INC (TCMD). Click either name above to swap in a different company.

TACTILE SYSTEMS TECHNOLOGY INC is the larger business by last-quarter revenue ($103.6M vs $75.1M, roughly 1.4× MEDIFAST INC). On growth, TACTILE SYSTEMS TECHNOLOGY INC posted the faster year-over-year revenue change (21.0% vs -36.9%). TACTILE SYSTEMS TECHNOLOGY INC produced more free cash flow last quarter ($16.8M vs $-6.6M). Over the past eight quarters, TACTILE SYSTEMS TECHNOLOGY INC's revenue compounded faster (30.2% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Dominion Voting Systems Corporation was a North American company that produced and sold electronic voting hardware and software, including voting machines and tabulators, in Canada and the United States.

MED vs TCMD — Head-to-Head

Bigger by revenue
TCMD
TCMD
1.4× larger
TCMD
$103.6M
$75.1M
MED
Growing faster (revenue YoY)
TCMD
TCMD
+57.9% gap
TCMD
21.0%
-36.9%
MED
More free cash flow
TCMD
TCMD
$23.4M more FCF
TCMD
$16.8M
$-6.6M
MED
Faster 2-yr revenue CAGR
TCMD
TCMD
Annualised
TCMD
30.2%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
TCMD
TCMD
Revenue
$75.1M
$103.6M
Net Profit
$10.6M
Gross Margin
69.4%
78.2%
Operating Margin
-10.4%
18.1%
Net Margin
10.3%
Revenue YoY
-36.9%
21.0%
Net Profit YoY
9.4%
EPS (diluted)
$-1.64
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
TCMD
TCMD
Q4 25
$75.1M
$103.6M
Q3 25
$89.4M
$85.8M
Q2 25
$105.6M
$78.9M
Q1 25
$115.7M
$61.3M
Q4 24
$119.0M
$85.6M
Q3 24
$140.2M
$73.1M
Q2 24
$168.6M
$73.2M
Q1 24
$174.7M
$61.1M
Net Profit
MED
MED
TCMD
TCMD
Q4 25
$10.6M
Q3 25
$-2.3M
$8.2M
Q2 25
$2.5M
$3.2M
Q1 25
$-772.0K
$-3.0M
Q4 24
$9.7M
Q3 24
$1.1M
$5.2M
Q2 24
$-8.2M
$4.3M
Q1 24
$8.3M
$-2.2M
Gross Margin
MED
MED
TCMD
TCMD
Q4 25
69.4%
78.2%
Q3 25
69.5%
75.8%
Q2 25
72.6%
74.5%
Q1 25
72.8%
74.0%
Q4 24
74.1%
75.2%
Q3 24
75.4%
75.0%
Q2 24
73.2%
73.9%
Q1 24
72.8%
71.1%
Operating Margin
MED
MED
TCMD
TCMD
Q4 25
-10.4%
18.1%
Q3 25
-4.6%
12.8%
Q2 25
-1.0%
5.2%
Q1 25
-1.1%
-7.4%
Q4 24
0.6%
14.6%
Q3 24
1.5%
9.3%
Q2 24
-4.7%
8.0%
Q1 24
4.5%
-4.9%
Net Margin
MED
MED
TCMD
TCMD
Q4 25
10.3%
Q3 25
-2.5%
9.6%
Q2 25
2.3%
4.1%
Q1 25
-0.7%
-4.9%
Q4 24
11.4%
Q3 24
0.8%
7.1%
Q2 24
-4.8%
5.9%
Q1 24
4.8%
-3.6%
EPS (diluted)
MED
MED
TCMD
TCMD
Q4 25
$-1.64
$0.45
Q3 25
$-0.21
$0.36
Q2 25
$0.22
$0.14
Q1 25
$-0.07
$-0.13
Q4 24
$0.08
$0.40
Q3 24
$0.10
$0.21
Q2 24
$-0.75
$0.18
Q1 24
$0.76
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
TCMD
TCMD
Cash + ST InvestmentsLiquidity on hand
$167.3M
$83.4M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$198.9M
$218.9M
Total Assets
$248.0M
$273.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
TCMD
TCMD
Q4 25
$167.3M
$83.4M
Q3 25
$173.5M
$66.0M
Q2 25
$162.7M
$81.5M
Q1 25
$164.6M
$83.6M
Q4 24
$162.3M
$94.4M
Q3 24
$170.0M
$82.1M
Q2 24
$163.5M
$73.6M
Q1 24
$156.4M
$60.7M
Total Debt
MED
MED
TCMD
TCMD
Q4 25
$0
Q3 25
$0
Q2 25
Q1 25
Q4 24
Q3 24
$27.0M
Q2 24
$27.8M
Q1 24
$28.5M
Stockholders' Equity
MED
MED
TCMD
TCMD
Q4 25
$198.9M
$218.9M
Q3 25
$214.7M
$204.9M
Q2 25
$216.0M
$194.9M
Q1 25
$211.0M
$205.6M
Q4 24
$210.1M
$216.6M
Q3 24
$207.3M
$207.9M
Q2 24
$205.3M
$200.7M
Q1 24
$211.0M
$193.5M
Total Assets
MED
MED
TCMD
TCMD
Q4 25
$248.0M
$273.9M
Q3 25
$268.2M
$259.2M
Q2 25
$269.3M
$273.0M
Q1 25
$280.0M
$280.2M
Q4 24
$284.2M
$297.9M
Q3 24
$291.2M
$287.7M
Q2 24
$293.5M
$278.8M
Q1 24
$302.8M
$272.0M
Debt / Equity
MED
MED
TCMD
TCMD
Q4 25
0.00×
Q3 25
0.00×
Q2 25
Q1 25
Q4 24
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
TCMD
TCMD
Operating Cash FlowLast quarter
$-5.3M
$17.3M
Free Cash FlowOCF − Capex
$-6.6M
$16.8M
FCF MarginFCF / Revenue
-8.8%
16.2%
Capex IntensityCapex / Revenue
1.8%
0.5%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$40.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
TCMD
TCMD
Q4 25
$-5.3M
$17.3M
Q3 25
$12.1M
$10.3M
Q2 25
$-3.4M
$14.8M
Q1 25
$3.4M
$417.0K
Q4 24
$-4.9M
$16.3M
Q3 24
$9.1M
$10.3M
Q2 24
$13.1M
$13.1M
Q1 24
$7.3M
$924.0K
Free Cash Flow
MED
MED
TCMD
TCMD
Q4 25
$-6.6M
$16.8M
Q3 25
$10.8M
$9.2M
Q2 25
$-4.8M
$14.4M
Q1 25
$1.9M
$38.0K
Q4 24
$-7.2M
$15.9M
Q3 24
$7.7M
$9.3M
Q2 24
$11.1M
$12.6M
Q1 24
$5.4M
$442.0K
FCF Margin
MED
MED
TCMD
TCMD
Q4 25
-8.8%
16.2%
Q3 25
12.0%
10.8%
Q2 25
-4.5%
18.2%
Q1 25
1.6%
0.1%
Q4 24
-6.1%
18.5%
Q3 24
5.5%
12.7%
Q2 24
6.6%
17.3%
Q1 24
3.1%
0.7%
Capex Intensity
MED
MED
TCMD
TCMD
Q4 25
1.8%
0.5%
Q3 25
1.5%
1.3%
Q2 25
1.3%
0.5%
Q1 25
1.3%
0.6%
Q4 24
1.9%
0.5%
Q3 24
1.0%
1.3%
Q2 24
1.1%
0.7%
Q1 24
1.1%
0.8%
Cash Conversion
MED
MED
TCMD
TCMD
Q4 25
1.63×
Q3 25
1.26×
Q2 25
-1.36×
4.59×
Q1 25
Q4 24
1.68×
Q3 24
8.04×
1.99×
Q2 24
3.06×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

TCMD
TCMD

Private Insurers$57.6M56%
Medicare$24.6M24%
Durable Medical Equipment Distributors$14.1M14%
Veterans Administration$7.3M7%

Related Comparisons